SEC 13F Intelligence

SIO GENE THERAPIES INC

CUSIP 829399104

Sio Gene Therapies Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 0 shares worth $0 as of Q2 2025.

Institutional Holders
1
Q2 2025
Reported Value
$0
Ticker
unmapped
private placement or foreign
Quarters Tracked
19

Ownership Trend

Institutional holders
Q4 ’20: 47Q4 ’20Q1 ’21: 44Q2 ’21: 38Q3 ’21: 40Q3 ’21Q4 ’21: 35Q1 ’22: 26Q2 ’22: 24Q2 ’22Q3 ’22: 25Q4 ’22: 29Q1 ’23: 5Q1 ’23Q2 ’23: 2Q3 ’23: 1Q4 ’23: 1Q4 ’23Q1 ’24: 1Q2 ’24: 1Q3 ’24: 1Q3 ’24Q4 ’24: 1Q1 ’25: 1Q2 ’25: 1Q2 ’25filingsflow.com
Total reported value
Q4 ’20: $40MQ4 ’20Q1 ’21: $50MQ2 ’21: $50MQ3 ’21: $33MQ3 ’21Q4 ’21: $25MQ1 ’22: $11MQ2 ’22: $7MQ2 ’22Q3 ’22: $5MQ4 ’22: $6MQ1 ’23: $1MQ1 ’23Q2 ’23: $26,000Q3 ’23: $0Q4 ’23: $0Q4 ’23Q1 ’24: $0Q2 ’24: $0Q3 ’24: $0Q3 ’24Q4 ’24: $0Q1 ’25: $0Q2 ’25: $0Q2 ’25filingsflow.com

Holders

··
Export to Excel
Manager% of PortfolioValueSharesQuarter
CONCOURSE FINANCIAL GROUP SECURITIES, INC.$0 AUM—$00Q2 2025

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.